RxDoctor Payments DataLook up a doctor →

Robert Pearlstein, DO

Geriatric Medicine · Plymouth Meeting, PANPI 1598788689

Payments from drug & device makers

$76,385in general payments, 2019–2025

Across 718 payments — averaging $106.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$55K
  • Eisai Inc.$6K
  • Sunovion Pharmaceuticals Inc.$1K
  • Pfizer$1K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Acadia Pharmaceuticals Inc$962
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly1$55,395
Eisai Inc.10$6,381
Sunovion Pharmaceuticals Inc.69$1,274
Pfizer76$1,246
Otsuka America Pharmaceutical, Inc.40$1,058
Acadia Pharmaceuticals Inc39$962
Teva Pharmaceuticals USA, Inc.42$887
AstraZeneca(2 entities)32$750
UCB, Inc.22$578
Lilly USA, LLC35$533
Sumitomo Pharma America, Inc.24$511
Avanir Pharmaceuticals, Inc.19$439
Johnson & Johnson20$374
Biogen7$340
Astellas Pharma US Inc15$325
Novartis16$323
Neurocrine Biosciences, Inc.15$319
E.r. Squibb & Sons, L.L.C.14$277
Sun Pharmaceutical Industries Inc.7$233
AbbVie(2 entities)14$230
Bayer12$221
Amneal Pharmaceuticals LLC3$149
Akcea Therapeutics, Inc.7$145
Alpha Cognition USA, Inc.1$141
Collegium Pharmaceutical, Inc.7$138
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$138
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$134
Kyowa Kirin, Inc.8$131
Boehringer Ingelheim7$127
Amarin Pharma, Inc.8$127
Paratek Pharmaceuticals, Inc.8$126
GSK7$121
Abbott4$120
SK Life Science, Inc.6$110
Daiichi Sankyo Inc.5$99
Xeris Pharmaceuticals, Inc.5$95
Novo Nordisk5$87
Nestle Healthcare Nutrition Inc.4$86
Vivus LLC5$85
Lundbeck LLC4$81
Neurelis, Inc.4$70
Amgen4$69
Ardelyx, Inc.3$63
Scilex Pharmaceuticals Inc.3$63
Verona Pharma, Inc.3$61
Biohaven Pharmaceutical Holding Company Ltd.3$58
Inspire Medical Systems, Inc.3$57
Shield Therapeutics Inc1$56
Urovant Sciences Inc3$49
Axsome Therapeutics, Inc.2$49
Boston Scientific3$49
Exact Sciences2$47
Alkermes, Inc.2$46
Mannkind Corporation1$43
Radius Health, Inc.3$41
Medtronic2$40
CMP Pharma, Inc.2$37
Noven Therapeutics, LLC2$34
Smith+Nephew2$33
Ferring Pharmaceuticals Inc.2$33

How this compares

$76,385 in reported general payments places this provider in the 95th percentile of 217 geriatric medicine providers in Pennsylvania.

See all geriatric medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$410,428
Medicare patients
1,867
Services billed
4,203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other geriatric medicine in Plymouth Meeting

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →